192 related articles for article (PubMed ID: 9559229)
1. Differential diagnosis of hepatic tumors with delayed enhancement at gadolinium-enhanced MRI: a pictorial essay.
Awaya H; Ito K; Honjo K; Fujita T; Matsumoto T; Matsunaga N
Clin Imaging; 1998; 22(3):180-7. PubMed ID: 9559229
[TBL] [Abstract][Full Text] [Related]
2. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MRI of focal liver tumors using a hepatobiliary MR contrast agent: detection and differential diagnosis using Gd-EOB-DTPA-enhanced versus Gd-DTPA-enhanced MRI in the same patient.
Hammerstingl R; Zangos S; Schwarz W; Rosen T; Bechstein WO; Balzer T; Vogl TJ
Acad Radiol; 2002 May; 9 Suppl 1():S119-20. PubMed ID: 12019845
[No Abstract] [Full Text] [Related]
4. Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.
Thian YL; Riddell AM; Koh DM
Cancer Imaging; 2013 Dec; 13(4):567-79. PubMed ID: 24434892
[TBL] [Abstract][Full Text] [Related]
5. MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
Grazioli L; Kirchin M; Pirovano G; Spinazzi A
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S61-4. PubMed ID: 10608399
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions.
Chiu FY; Jao JC; Chen CY; Liu GC; Jaw TS; Chiou YY; Hsu FO; Hsu JS
J Comput Assist Tomogr; 2005; 29(2):176-80. PubMed ID: 15772533
[TBL] [Abstract][Full Text] [Related]
7. The ins and outs of liver imaging.
O'Neill EK; Cogley JR; Miller FH
Clin Liver Dis; 2015 Feb; 19(1):99-121. PubMed ID: 25454299
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic imaging of hepatic lesions in adults.
Lamba R; Fananapazir G; Corwin MT; Khatri VP
Surg Oncol Clin N Am; 2014 Oct; 23(4):789-820. PubMed ID: 25246050
[TBL] [Abstract][Full Text] [Related]
9. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal hepatic lesions with SPIO-enhanced MRI.
Zheng WW; Zhou KR; Chen ZW; Shen JZ; Chen CZ; Zhang SJ
World J Gastroenterol; 2002 Feb; 8(1):82-6. PubMed ID: 11833077
[TBL] [Abstract][Full Text] [Related]
11. Fat-suppressed dynamic and delayed gadolinium-enhanced volumetric interpolated breath-hold magnetic resonance imaging of cholangiocarcinoma.
Leyendecker JR; Gakhal M; Elsayes KM; McDermott R; Narra VR; Brown JJ
J Comput Assist Tomogr; 2008; 32(2):178-84. PubMed ID: 18379298
[TBL] [Abstract][Full Text] [Related]
12. ACG clinical guideline: the diagnosis and management of focal liver lesions.
Marrero JA; Ahn J; Rajender Reddy K;
Am J Gastroenterol; 2014 Sep; 109(9):1328-47; quiz 1348. PubMed ID: 25135008
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of focal hepatic lesions with ultrasound contrast agents.
Sutherland T; Temple F; Lee WK; Hennessy O
J Clin Ultrasound; 2011 Sep; 39(7):399-407. PubMed ID: 21674510
[TBL] [Abstract][Full Text] [Related]
14. MRI of small intrahepatic mass-forming cholangiocarcinoma and atypical small hepatocellular carcinoma (≤3 cm) with cirrhosis and chronic viral hepatitis: a comparative study.
Sheng RF; Zeng MS; Rao SX; Ji Y; Chen LL
Clin Imaging; 2014; 38(3):265-72. PubMed ID: 24559750
[TBL] [Abstract][Full Text] [Related]
15. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
Park HJ; Kim YK; Park MJ; Lee WJ
Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
[TBL] [Abstract][Full Text] [Related]
16. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
17. Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI.
Kim YK; Han YM; Kim CS
Eur J Radiol; 2009 Apr; 70(1):94-100. PubMed ID: 18316169
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Sclerosed Hemangioma: a case report and review of the literature.
Miyamoto S; Oshita A; Daimaru Y; Sasaki M; Ohdan H; Nakamitsu A
BMC Surg; 2015 Apr; 15():45. PubMed ID: 25927893
[TBL] [Abstract][Full Text] [Related]
19. [A case of sclerosed hemangioma mimicking intrahepatic cholangiocarcinoma].
Park SM; Shin SM; Seo HE; Kim SH; Kim HS; Park JH; Kim JH; Sohn KR
Korean J Gastroenterol; 2009 Dec; 54(6):399-403. PubMed ID: 20026896
[TBL] [Abstract][Full Text] [Related]
20. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
